Immunohistochemical analysis of lyme disease in the skin of naive and infection-immune rabbits following challenge

Infection and Immunity

Volumn 69, Issue 6, 2001, Pages 4094-4102

  Chong Cerrillo, C ^a   Shang, E S ^a   Blanco, D R ^a   Lovett, M A ^a   Miller, J N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; BORRELIA BURGDORFERI; CELL INFILTRATION; IMMUNOHISTOCHEMISTRY; LYME DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SKIN; SPIROCHETE;

ANIMALS; BORRELIA BURGDORFERI GROUP; DISEASE MODELS, ANIMAL; ERYTHEMA CHRONICUM MIGRANS; HUMANS; IMMUNITY, CELLULAR; IMMUNOHISTOCHEMISTRY; LYME DISEASE; MALE; MICE; MICE, INBRED C3H; RABBITS; SKIN;

EID: 0035010026     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.6.4094-4102.2001     Document Type: Article

References (48)

1. Chronic neurologic manifestations of erythema migrans borreliosis
2. A new animal model for studying Lyme disease spirochetes in a mammalian host-adapted state
3. Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue
4. Effect of anti-interteukin 12 treatment on murine lyme borreliosis
5. Effect of anti-interleukin 12 treatment on murine lyme borreliosis
6. Ablation of interleukin-12 exacerbates Lyme arthritis in SCID mice
7. Isolation and cultivation of Lyme disease spirochetes
8. Lyme borreliosis in selected strains and ages of laboratory mice
9. Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice
10. DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies
11. A 9.0-kilobase-pair circular plasmid of Borrelia burgdorferi encodes an exported protein: Evidence for expression only during infection
12. Immune serum from rabbits infected with Borrelia burgdorferi B31 confers complete passive protection against homologous challenge
13. Histopathology of clinical phases of human Lyme disease
14. Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity
15. Rabbit model of Lyme borreliosis: Erythema migrans, infection-derived immunity, and identification of Borrelia burgdorferi proteins associated with virulence and protective immunity
16. The pathogenesis of Lyme disease
17. Decorin-binding protein A (DbpA) of Borrelia burgdorferi is not protective when immunized mice are challenged via tick infestation and correlates with the lack of DbpA expression by B. burgdorferi in ticks
18. Histopathology of Lyme arthritis in LSH hamsters
19. Genetic heterogenity of the genes coding for the outer surface protein C (OspC) and the flagellin of Borrelia burgdorferi
20. T-helper-cell cytokines in the early evolution of murine Lyme arthritis
21. Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice
22. Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice
23. T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice
24. Chronic neurologic manifestations of Lyme disease
25. T helper phenotype and genetic susceptibility in experimental Lyme disease
26. Borrelia burgdorferi-pulsed dendritic cells induce a protective immune response against tick-transmitted spirochetes
27. Experimental chronic Lyme borreliosis in Lewis rats
28. Lyme disease - United States, 1996
29. Central nervous system manifestations of Lyme disease
30. The triad of neurologic manifestations of Lyme disease: Meningitis, cranial neuritis, and radiculoneuritis
31. Early and early disseminated phases of Lyme disease in the rhesus monkey: A model for infection in humans
32. Persistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human Lyme disease
33. Specific Th1 cell lines that confer protective immunity against experimental Borrelia burgdorferi infection in mice
34. Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis
35. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding
36. Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A
37. A guinea pig model for Lyme disease
38. Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy
39. Lyme disease
40. Lyme carditis: Cardiac abnormalities of Lyme disease
41. The spirochetal etiology of Lyme disease
42. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum
43. The clinical evolution of Lyme arthritis
44. Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi
45. Borrelia burgdorferi genes selectively expressed in the infected host
46. Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo
47. Suppression of acute Ixodes scapularis-induced Borrelia burgdorferi infection using tumor necrosis factor-alpha, interleukin-2, and interferon-gamma
48. Effects of Ixodes scapularis and Borrelia burgdorferi on modulation of the host immune response: Induction of a TH2 cytokine response in Lyme disease-susceptible (C3H/HeJ) mice but not in disease-resistant (BALB/c) mice